drugset / Trial / NCT00985439

Study of Diclofenac Capsules to Treat Dental Pain

NCT00985439

Phase 2 Completed 202 enrolled Iroko Pharmaceuticals, LLC
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether Diclofenac Test Formulation Capsules are safe and effective for the treatment of dental pain.

Timeline

Start
2009-09
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Celecoxib Other / unclassified 400 mg
Subject Diclofenac Other / unclassified 18 mg
Subject Diclofenac Other / unclassified 35 mg

Indications

No indication recorded.